{"name": "OrSense",
 "permalink": "orsense",
 "crunchbase_url": "http://www.crunchbase.com/company/orsense",
 "homepage_url": "http://www.orsense.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "orsense@orsense.com",
 "phone_number": "972-8-9465142",
 "description": "",
 "created_at": "Mon May 02 13:51:30 UTC 2011",
 "updated_at": "Mon May 02 13:58:22 UTC 2011",
 "overview": "\u003Cp\u003EOrSense is a medical device company that develops and commercializes patient monitoring solutions for non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose and other blood parameters. OrSense\u0026#8217;s NBM-200MP monitors and displays oxygen saturation of Hb (SpO2), low signal oximetry, SpO2, pulse rate, plethysmogram and hemoglobin, all non-invasively and continuously. The system is designed for use in hospitals including operating and recovery rooms and intensive care units as well as in outpatient sites and emergency services. OrSense\u00e2\u20ac\u2122s non-invasive hemoglobin/hematocrit monitor was granted the CE approval and was tested on over 4,000 patients and donors at 15 sites in the U.S. and Europe. The Company\u0026#8217;s products are based on its proprietary Occlusion Spectroscopy technology, which overcomes key obstacles that hinder the performance of competing approaches.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       51],
      "assets/images/resized/0013/2844/132844v1-max-150x150.jpg"],
     [[185,
       64],
      "assets/images/resized/0013/2844/132844v1-max-250x250.jpg"],
     [[185,
       64],
      "assets/images/resized/0013/2844/132844v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$18M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.businesswire.com/news/home/20110502005785/en/OrSense-Closes-U.S.-18-Million-Private-Financing",
    "source_description": "OrSense Closes U.S. $18 Million Private Financing to Accelerate Commercialization of Its Non-Invasive Monitoring Products",
    "raised_amount": 18000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 5,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Israel Healthcare Ventures",
         "permalink": "israel-healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               72],
              "assets/images/resized/0006/1395/61395v1-max-150x150.jpg"],
             [[212,
               102],
              "assets/images/resized/0006/1395/61395v1-max-250x250.jpg"],
             [[212,
               102],
              "assets/images/resized/0006/1395/61395v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Star Ventures",
         "permalink": "star-ventures",
         "image":
          {"available_sizes":
            [[[150,
               56],
              "assets/images/resized/0003/1009/31009v1-max-150x150.png"],
             [[250,
               94],
              "assets/images/resized/0003/1009/31009v1-max-250x250.png"],
             [[259,
               98],
              "assets/images/resized/0003/1009/31009v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Lewis Trust Group",
         "permalink": "lewis-trust-group",
         "image":
          {"available_sizes":
            [[[103,
               55],
              "assets/images/resized/0010/2616/102616v1-max-150x150.png"],
             [[103,
               55],
              "assets/images/resized/0010/2616/102616v1-max-250x250.png"],
             [[103,
               55],
              "assets/images/resized/0010/2616/102616v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "5 Golda Meir St",
    "address2": "Weizmann Science Park, P.O.Box 4052",
    "zip_code": "74140",
    "city": "Nes Ziona",
    "state_code": null,
    "country_code": "ISR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        105],
       "assets/images/resized/0013/2845/132845v1-max-150x150.jpg"],
      [[250,
        175],
       "assets/images/resized/0013/2845/132845v1-max-250x250.jpg"],
      [[450,
        316],
       "assets/images/resized/0013/2845/132845v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}